← Open Payments lookup

DORNA YAGHOOBZADEH: Open Payments

NPI 1760969943 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,155 in 232 payments from 18 companies in 2025. Trend: 2023 $3,545 · 2024 $4,127 · 2025 $4,155

Food & beverage: $4,070Education: $85
CompanyPaymentsAmount
ABBVIE INC.50$994
Salix Pharmaceuticals, a division of Bausch Health US, LLC72$921
Janssen Biotech, Inc.22$416
QOL Medical, LLC12$297
Takeda Pharmaceuticals U.S.A., Inc.16$247
Ardelyx, Inc.12$226
PFIZER INC.12$222
Regeneron Healthcare Solutions, Inc.10$213
GENZYME CORPORATION4$113
Aimmune Therapeutics, Inc.4$105

Products named: XIFAXAN, RINVOQ, TREMFYA, Sucraid, DUPIXENT, SKYRIZI, IBSRELA, ENTYVIO.

Industry payments across CA — which companies pay providers there.